Use of OB-101 to treat ocular inflammation
Abstract
A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of inflammation in both the anterior and posterior portions of the eye.
Collections
Citation
Chiou, George C. Y. (1993). Use of OB-101 to treat ocular inflammation. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from http : / /hdl .handle .net /1969 .1 /177526.